Manufacturing Advisory Committee (MAC) supports the UK commercial bio-medicine manufacturing community by providing an experienced network for members to address issues relevant to the biologics, vaccine, cell and gene therapy sector, to cross-pollinate expertise and best practice.

MAC has a significant presence on the Medicines Manufacturing Industry Partnership (MMIP), which reports at the Ministerial level, bringing the whole UK industry together to drive UK competitiveness in medicines manufacturing. It also supports the work of the BIA Covid-19 Expert Advisory Group that feeds into the HMG Vaccines Taskforce. The committee is networked into Catapults, supporting the skills strategy of the Cell and Gene Therapy Catapult, and UK Centres of Excellence.

MAC is responsible for the scientific programme each year for one of the BIA's successful flagship events - the bioProcessUK Conference.

The committee has reviewed and responded to several manufacturing-related consultations from the European Commission and contributes to the MHRA GMP/GDP Consultative Committee.

MAC Priorities

1. Connect
  • 32 members spanning biologics, vaccines and cell & gene therapies cross-pollinating expertise and best practice through networking and site visits
2. Inform/Support
  • Deliver another successful programme for the 2022 bioProcessUK conference
  • Contribute to the 2022 UK Bioscience Forum if appropriate
  • Aid in delivering a national skills provision for biomanufacturing for global impact
  • Continue to support the Covid-19 vaccine BIA Expert Advisory Group
  • Support BIA Communications Group to increase public awareness of BIA by engaging in activities to improve online public-facing content
3. Expert Advice
  • How can MAC support Net Zero
  • Key pan-industry stakeholder within Life Sciences Vision:
    • Several MAC members represent the voice of the biologics and cell & gene therapy sector on the MMIP Leadership Team, seeking wider MAC contribution when appropriate
    • Deliver next-generation analytics and associated data strategic vision for the industry 
    • Support UK manufacturing and supply chain investment and growth for resilience, and to meet the 100-day challenge
  • Represent BIA at the MHRA GMP/GDP consultative committee meetings

People icon

BIA MAC Leadership Programme (MAC LeaP) 

The BIA MAC LeaP programme supports the development and training of managers in the biopharmaceutical and cell & gene therapy industries through cross-sector learning and peer networks. 

 

Network icon

Advanced Therapies Apprenticeship Community (ATAC)

ATAC was established to develop apprenticeship programmes designed specifically to train and upskill individuals to develop, manufacture and deliver advanced therapies, vaccines and biologics at scale. The programme currently supports over 230 apprentices from 45 organisations across science, digital, engineering and leadership disciplines addressing critical skills gaps in our sector. MAC supports this programme, coordinated by the CGT Catapult.

Books icon

Next-Generation Analytics

In partnership with the CGT Catapult & KTN, MAC held a workshop in June 2019 to discuss key challenges, barriers and opportunities for the development and integration of analytical technologies to support advanced manufacturing. Representatives of large pharma, SMEs, biopharma, technology developers, national measurement laboratories, RTOs & CDMO/CROs discussed what analytical innovation is needed to accelerate growth within the industry.

 


Members of BIA MAC